The Current State of Missouri’s Overdose Crisis & Recent Mitigation Strategies

Speaker(s):

Winograd, Rachel, PhD

Presentation:

This talk will describe the recent landscape of drug use and overdose deaths in Missouri, including the ever-expanding role of fentanyl in our drug supply and the increase in deaths involving stimulants like methamphetamine and cocaine. Though ongoing initiatives funded by the State Opioid Response grant have understandably continued to focus on increasing access to medical treatments for Opioid Use Disorder and opioid-related harm reduction initiatives, the necessity of greater implementation of stimulant-focused intervention strategies is clear. To that end, this presentation will provide an overview of Missouri’s Contingency Management pilot programs for people with Stimulant Use Disorder, as well as harm reduction training, education, and drug checking resources designed for people who use stimulants. Additional attention will be paid to the widening racial disparities between Black and White Missourians regarding addiction treatment outcomes and overdose fatalities, including highlights of what is being done at the state and local levels to reduce deaths among those at highest-risk. Strategies for data-driven drug policy, funding, and community engagement will be highlighted.

 

Objectives:

  1. Describe the difference between fentanyl and stimulant contamination vs. co-use of both substances
  2. Define the behavioral basis of Contingency Management as a treatment approach
  3. Describe how and why individuals who use drugs may benefit from using fentanyl test strips

Winograd, Rachel, PhD

Rachel Winograd, PhD, is an Associate Professor in the Department of Psychological Sciences and licensed psychologist at the University of Missouri St. Louis with a dual appointment within the Missouri Institute of Mental Health where she directs the Addiction Science team. She received her doctorate in clinical psychology from the University of Missouri, Columbia, and completed her doctoral internship with the VA St. Louis Healthcare System. Her clinical, research, and program development interests revolve around interventions designed to save and improve the lives of people who use drugs. Her primary focus is on expanding access to medical treatment, harm reduction strategies, and person-centered approaches for those most in need of evidence-based care for substance use disorders in Missouri.

Presentation(s): 

Five Years of Missouri’s Medication First Approach to Opioid Use Disorder: What We’ve Learned and Where We Go From Here

 

 

Cummins, Duane, PhD

During the past 37 years Dr. Cummins has functioned in a variety of different positions within the Missouri Department of Corrections and the Missouri Department of Mental Health, as well as having served Gateway Foundation in numerous markets. Duane has had the opportunity to train employees in a wide range of professional disciplines and has participated in the development of numerous original offender programs and program designs. Duane has a substantial grasp of the unique issues presented by individuals expressing both substance use and criminal behavior often compounded by other mental health conditions.

Presentation(s): 

The Changing Face of Corrections Based Substance Use Services